Publicaciones en las que colabora con ANDREE YERAMIAN HAKIM (32)
2024
-
Sprouty1 is a broad mediator of cellular senescence
Cell Death and Disease, Vol. 15, Núm. 4
2023
-
In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers
Advanced Science, Vol. 10, Núm. 32
-
Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling
Biomedicine and Pharmacotherapy, Vol. 168
2022
-
A dominant negative mutation uncovers cooperative control of caudal Wolffian duct development by Sprouty genes
Cellular and Molecular Life Sciences, Vol. 79, Núm. 10
-
Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition
Scientific Reports, Vol. 12, Núm. 1
2017
-
A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-β in mouse endometrium
Cell Death and Differentiation, Vol. 24, Núm. 8, pp. 1443-1458
-
Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer
Autophagy, Vol. 13, Núm. 3, pp. 608-624
-
Endometrial carcinoma: Specific targeted pathways
Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 149-207
2016
-
2-phenylethynesulphonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels
Pigment Cell and Melanoma Research, Vol. 29, Núm. 3, pp. 352-371
-
Bioluminescence Imaging to Monitor the Effects of the Hsp90 Inhibitor NVP-AUY922 on NF-κB Pathway in Endometrial Cancer
Molecular Imaging and Biology, Vol. 18, Núm. 4, pp. 545-556
2014
2013
-
Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells
Molecular Oncology, Vol. 7, Núm. 4, pp. 763-775
-
Endometrial carcinoma: Molecular alterations involved in tumor development and progression
Oncogene, Vol. 32, Núm. 4, pp. 403-413
-
Long-term estradiol exposure is a direct mitogen for insulin/EGF-primed endometrial cells and drives PTEN loss-induced hyperplasic growth
American Journal of Pathology, Vol. 183, Núm. 1, pp. 277-287
2012
-
Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells
Molecular Oncology, Vol. 6, Núm. 5, pp. 530-541
-
Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: Role for proteins involved in resistance to apoptosis and hypoxia
Histopathology, Vol. 60, Núm. 3, pp. 460-471
-
Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway
International Journal of Cancer, Vol. 130, Núm. 4, pp. 967-978
2011
-
KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels
American Journal of Pathology, Vol. 178, Núm. 4, pp. 1529-1543
-
Nuclear factor-B2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner
Laboratory Investigation, Vol. 91, Núm. 6, pp. 859-871
-
Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma
Human Pathology, Vol. 42, Núm. 2, pp. 185-193